Product Code: GVR-4-68040-831-9
U.S. Compression Tape Market Summary
The U.S. compression tape market size was estimated at USD 34.79 million in 2025 and is expected to reach USD 46.18 million by 2033, growing at a CAGR of 3.68% from 2026 to 2033. The market is expanding as healthcare providers increase the use of compression solutions for injury management, post-operative care, and swelling control. Growing participation in sports and fitness is driving higher demand for preventive and recovery-focused taping. Hospitals, outpatient centers, and home-care settings are adopting compression products to support faster mobilization and reduce secondary complications. Broader access through retail and e-commerce channels is further supporting volume growth across user groups.
The U.S. compression tape market continues to expand, driven by growing use of adhesive and wrap-style products for localized compression. Demand is supported by rising incidence of venous and lymphatic conditions such as chronic venous insufficiency, deep-vein thrombosis, post-thrombotic syndromes, and lymphedema. Increasing surgical volumes, obesity, and inactive lifestyles further contribute to utilization, with compression tapes used across hospital, outpatient, and home-care settings for swelling management, stabilization, and post-procedure support.
U.S. Compression Tape Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. compression tape market report based on indication, and compression class.
- Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Sports Injuries
- Post-operative Edema
- Lymphedema
- Compression Class Outlook (Revenue, USD Million, 2021 - 2033)
- Class 1
- Class 2
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Indication
- 1.2.2. Compression class
- 1.2.3. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Indication Outlook
- 2.2.2. Compression class outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Compression Tape Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising incidence of venous and lymphatic conditions
- 3.2.1.2. Expansion of sports activity and injury rates
- 3.2.1.3. Innovation in elastic/cohesive wrap technology
- 3.2.2. Market Restraint Impact Analysis
- 3.2.2.1. Alternative Treatment Options
- 3.2.2.2. Adverse Effects Associated with Compression Therapy
- 3.2.3. Market Opportunity Impact Analysis
- 3.2.3.1. Product innovation in materials and hybrid formats
- 3.2.3.2. Increasing Number of Clinical Trials
- 3.2.4. Market Challenge Impact Analysis
- 3.3. U.S. Compression Tape Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Reimbursement Scenario
Chapter 4. U.S. Compression Tape Market: Indication Estimates & Trend Analysis
- 4.1. Indication Market Share, 2025 & 2033
- 4.2. Segment Dashboard
- 4.3. U.S. Compression Tape Market by Indication Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.4.1. Sports Injuries
- 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.2. Post-operative Edema
- 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.3. Lymphedema
- 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. U.S. Compression Tape Market: Compression Class Estimates & Trend Analysis
- 5.1. Compression Class Market Share, 2025 & 2033
- 5.2. Segment Dashboard
- 5.3. U.S. Compression Tape Market by Compression Class Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 5.4.1. Class 1
- 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.2. Class 2
- 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis By Key Market Participants
- 6.2. Company/Competition Categorization
- 6.3. Vendor Landscape
- 6.3.1. List of key distributors and channel partners
- 6.3.2. Key customers
- 6.3.3. Key company market share analysis, 2024/2025
- 6.4. Company Profiles
- 6.4.1. Essity Aktiebolag
- 6.4.1.1. Company overview
- 6.4.1.2. Financial performance
- 6.4.1.3. Product benchmarking
- 6.4.1.4. Strategic initiatives
- 6.4.2. Hartmann AG
- 6.4.2.1. Company overview
- 6.4.2.2. Financial performance
- 6.4.2.3. Product benchmarking
- 6.4.2.4. Strategic initiatives
- 6.4.3. Medline Industries, LP.
- 6.4.3.1. Company overview
- 6.4.3.2. Financial performance
- 6.4.3.3. Product benchmarking
- 6.4.3.4. Strategic initiatives
- 6.4.4. 3M
- 6.4.4.1. Company overview
- 6.4.4.2. Financial performance
- 6.4.4.3. Product benchmarking
- 6.4.4.4. Strategic initiatives
- 6.4.5. Mueller Sports Medicine
- 6.4.5.1. Company overview
- 6.4.5.2. Financial performance
- 6.4.5.3. Product benchmarking
- 6.4.5.4. Strategic initiatives
- 6.4.6. Dynarex
- 6.4.6.1. Company overview
- 6.4.6.2. Financial performance
- 6.4.6.3. Product benchmarking
- 6.4.6.4. Strategic initiatives
- 6.4.7. DeRoyal
- 6.4.7.1. Company overview
- 6.4.7.2. Financial performance
- 6.4.7.3. Product benchmarking
- 6.4.7.4. Strategic initiatives
- 6.4.8. Andover Healthcare
- 6.4.8.1. Company overview
- 6.4.8.2. Financial performance
- 6.4.8.3. Product benchmarking
- 6.4.8.4. Strategic initiatives
- 6.4.9. Cardinal Health
- 6.4.9.1. Company overview
- 6.4.9.2. Financial performance
- 6.4.9.3. Product benchmarking
- 6.4.9.4. Strategic initiatives